P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness.
about
The P2X7 receptor is a key modulator of aerobic glycolysisMolecular and functional properties of P2X receptors--recent progress and persisting challengesPurinergic signalling and cancerEmergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterialsCalcium influx pathways in breast cancer: opportunities for pharmacological interventionThe P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.P2X7 targeting inhibits growth of human mesotheliomaGenetic ablation of the fatty acid-binding protein FABP5 suppresses HER2-induced mammary tumorigenesis.Carcinoma-specific expression of P2Y11 receptor and its contribution in ATP-induced purinergic signalling and cell migration in human hepatocellular carcinoma cells.Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma.P2X receptors: New players in cancer pain.P2X7 receptor activation impairs exogenous MHC class I oligopeptides presentation in antigen presenting cells.Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis.Ion channels and transporters [corrected] in cancer. 2. Ion channels and the control of cancer cell migrationExpression and contributions of TRPM7 and KCa2.3/SK3 channels to the increased migration and invasion of microglia in anti-inflammatory activation statesP2X7 mediates ATP-driven invasiveness in prostate cancer cells.Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonistsP2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma.P2X7 Receptor Function in Bone-Related Cancer.The expression of P2X₇ receptors in EPCs and their potential role in the targeting of EPCs to brain gliomasEpigenetic alteration of the purinergic type 7 receptor in salivary epithelial cells.Post-translational allosteric activation of the P2X7 receptor through glycosaminoglycan chains of CD44 proteoglycansP2Y2 receptor promotes cell invasion and metastasis in prostate cancer cellsActivation of TRPV2 and BKCa channels by the LL-37 enantiomers stimulates calcium entry and migration of cancer cells.Targeting of the P2X7 receptor in pancreatic cancer and stellate cells.SCN4B acts as a metastasis-suppressor gene preventing hyperactivation of cell migration in breast cancerNucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT).New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors.Roles of ion transport in control of cell motility.Role of ion channels in regulating Ca²⁺ homeostasis during the interplay between immune and cancer cells.An inhibitor of K+ channels modulates human endometrial tumor-initiating cells.Involvement of ion channels and transporters in carcinoma angiogenesis and metastasis.Potential role of P2X7R in esophageal squamous cell carcinoma proliferationPI3K/Akt signaling pathway triggers P2X7 receptor expression as a pro-survival factor of neuroblastoma cells under limiting growth conditions.A critical look at the function of the P2Y11 receptor.Extracellular purines, purinergic receptors and tumor growth.The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma.Autocrine signaling via release of ATP and activation of P2X7 receptor influences motile activity of human lung cancer cellsNatural compounds with P2X7 receptor-modulating properties.Molecular mechanisms of tumour invasion: regulation by calcium signals.
P2860
Q24296731-22C3CDC7-686F-4D4E-B510-6A15F9EF9751Q24617046-21A65F07-73F5-4541-85A4-6DB52973A301Q24618782-7D48D43C-C1BE-45F0-A514-A233766193E8Q26860518-0C9B38A0-B473-4AA9-8105-DF8DBEF60E23Q27025564-812CF9AE-99E4-455E-AB54-5717BFA9FA29Q27304392-633A9A11-EF9B-4038-82A7-63491D27A171Q28468633-8C4DBF80-3CDE-4ED8-B3BA-33E5A141D0F3Q33850093-5A3F22D4-B6D9-4D8D-8347-45FD93665326Q33913908-835BDF2A-CC0C-4369-B971-2AC0B4AFC66BQ34195588-CEB1D8D2-480B-4BBD-BDDD-0F47BAAF8481Q34567944-3954D3F5-BA41-49A8-A54A-AFCB9F13EAB0Q34935396-E7D5F545-D458-486C-910A-FC2BB253C049Q35044543-A293430E-5B99-4796-B5A5-0DAFBF303B68Q35216836-52196428-1A99-4862-9D9D-0F23B826DAEFQ35229982-EA629985-84E3-4D7A-80E1-A6777FD7DD44Q35500124-7B15C9DC-93B5-4C19-AC34-497A25F15C0FQ36092090-5106CDAF-40BA-4772-AFE0-0C14CBEA03FBQ36092896-27310B41-2435-40CC-8BDD-D0B754B20215Q36200053-E234152E-E744-4BA2-9590-064C1460FC39Q36215883-50113B1E-7CA5-491C-AF13-089F4F934666Q36641966-BA64E9B3-1B5B-42DE-A16C-C21DC7CF5F60Q37164400-FFDFE8B5-BF1B-440B-BA7D-504D3BBE2F8CQ37182251-D8DFAAB3-1F21-4D99-8D78-D82BD6D839EDQ37269132-8E748A0C-52D3-4795-91CD-15E49AB50A06Q37394235-6B64F2C2-0D2C-4FD6-A6E1-C0931777F1ACQ37492892-4E4F7EBF-8F9D-41D2-AAEA-408138A54951Q37677827-15BCAE29-1720-4EEA-9A8B-2985F65328FCQ38005034-624B2F09-0F0F-4B6B-80C8-B8714DDFFB64Q38110508-F6E13C75-6CE7-406D-A8A4-3757DACE1DA5Q38361335-BA0F872A-0BE6-45D8-99FF-FD17C3235371Q38502913-D17C4FD7-4699-4CDA-973B-8C65BBF1C78AQ38704738-D7B93BBD-C8C7-4E8C-B231-A0F5B53DBD5DQ38708131-91C79493-5CD2-4A58-A1D7-CA0F77D8AA74Q38810232-0B35F095-935E-4256-8800-02EC90E6F7E5Q38849452-2BD74816-6FC9-4DFE-B0C1-F7052ECFFC01Q38870205-1FAFFF34-10B9-4AC1-A93C-FAC5E6035CC6Q38916636-2D3B5514-E926-4C06-99BE-4F8D34D6077EQ39015711-11C7F1A7-F65D-4F16-84F8-5A61F27BB4E5Q39070001-1DA1BF0E-F6CD-42C9-9910-2CE9D31ADBD5Q39183513-FD340940-272E-416A-B85A-138035FC9640
P2860
P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
P2X(7) receptor activation enh ...... ent cancer cells invasiveness.
@en
type
label
P2X(7) receptor activation enh ...... ent cancer cells invasiveness.
@en
prefLabel
P2X(7) receptor activation enh ...... ent cancer cells invasiveness.
@en
P2093
P50
P356
P1433
P1476
P2X(7) receptor activation enh ...... ent cancer cells invasiveness.
@en
P2093
A Chantôme
A Surprenant
F Alcaraz-Pérez
M L Cayuela
P2888
P304
P356
10.1038/ONC.2010.593
P407
P577
2011-01-17T00:00:00Z
P5875
P6179
1036639557